SlideShare a Scribd company logo
1 of 31
Presented By:-
Sridhar S
1st M.Pharmacy
Pharmaceutical Regulatory
Affairs
JSS College of Pharmacy
Mysuru-15
Definition
 MedWatch is the Food and Drug Administration’s Safety
Information and Adverse Event Reporting Program. MedWatch
is used for reporting an adverse event, founded in 1993
 this system of voluntary reporting allows such information to
be shared with the medical community or the general public.
The system includes publicly available databases and online
analysis tools for professionals.
 MedWatch also disseminates medical product safety alerts such
as recalls and other clinical safety communications via
its website, email list
Reporting Adverse Events to FDA
 Industry
 ICH E2B electronic standard (clinical safety data
management)
 MedWatch form 3500A
 Public
 MedWatch 3500
 MedWatch 3500B
Med Watch program goals
 Reporting IN
 Educate about importance of reporting
 Facilitate the reporting
 Improve the quality of the reports
 Safety Information OUT
 Disseminate clinically useful, new safety information to
providers and patients
Mission and History
 “Protecting the public health by assuring the safety, efficacy,
and security of human ... drugs, biological products, medical
devices, cosmetics, and products that emit radiation.”( from
FDA Mission Statement)
 Helping the public get the accurate, science-based information
they need to use medicines and foods to improve their health
How FDA Evaluates Medical Product Safety
 Pre-Market Review and Approval
• FDA does not develop or routinely test products itself
• FDA reviews the results of laboratory, animal, and human
clinical testing done by companies
 Post-Market Monitoring for Safety
• Careful review of adverse experiences with products once
they are marketed
Reporting In to MedWatch
 What, when, how and why to report
 What
 All clinical medical products
 When
 If serious and any adverse reaction
 How
 Online, or mail/fax/phone
 Why
 Every report can make a difference
What is a serious adverse event
 1) Death
 2) Life-threatening adverse drug experience
 3) Inpatient hospitalization or prolongation of existing
hospitalization (for > 24 hours)
 4) Persistent or significant incapacity or substantial
disruption of the ability to conduct normal life functions
 5) Congenital anomaly/birth defect
 6) Important Medical Event (IME) that may not result in
death, be life threatening, or require hospitalization may
be considered a serious adverse drug experience
Forms to reporting to FDA
 FORM FDA 3500-Voluentary reporting
 For use by healthcare professionals, consumers, and patients.
Submit the completed form using built-in postage-paid mailer,
or fax.
 FORM FDA 3500B-Voluentary reporting for consumers
 A consumer-friendly version of the 3500 reporting
form. Submit the completed form using address on page 3 of
the form, or fax.
 FORM FDA 3500A-Mandatory reporting
 For use by IND reporters, manufacturers, distributors,
importers, user facilities personnel
 Online Reporting Form (Voluntary Reporting)
 Report serious adverse events online for human medical
products, including potential and actual product use errors,
product quality problems, and therapeutic
inequivalence/failure. The introductory page features additional
information and instructions.
PATIENT INFORMATION
Medical device
Product
detail
Reporter information
FORM 3500A FORM 3500B
Safety reporting portal
 To report adverse events with tobacco products or dietary
supplements online, use the Safety Reporting Portal
 Tobacco
 If you experience a problem with a tobacco product, such as an
unexpected health or safety issue, report it online using the
Safety Reporting Portal.
 Dietary Supplements
 Dietary supplements include vitamins, minerals, herbs,
amino acids, whey protein, creatine, and weight loss pills
 Radiation-emitting
Products
 The radiation emitting
products like medical
devices and radio isotopes
are reported to the FDA by
safety reporting portal
 Any accidental radiation
occurrences arising from
the manufacturing, testing,
or use of any product
introduced or intended to be
introduced into commerce
MedWatch Website Safety Reporting Information
Monthly Safety Summaries Individual Safety Alerts
Who Should Submit a Safety Report?
 Organizations and people in certain professional roles, such as
the following:-
 Food Manufacturers, Processors, Packers, and Holders
 Researchers
 An applicant of an approved drug product or a manufacturer,
distributor or packer listed on the label of any drug product
 Drug Manufacturers
 Dietary supplement manufacturers, packers, and distributors
 Others, including healthcare providers, public health
officials, and other professionals, as well as consumers
and concerned citizens, may voluntarily submit reports if
they encounter safety issues with a product and/or
unanticipated harmful effects that they believe are related
to a product.
What to Report to FDA MedWatch
 Use the MedWatch form to report adverse events that you
observe or suspect for human medical products, including
serious drug side effects, medication errors/product use errors,
product quality problems, and therapeutic failures for:-
 Prescription or over-the-counter medicines, as well as
medicines administered to hospital patients or at outpatient
infusion centers
 Biologics (including blood components, blood and plasma
derivatives, allergenic, human cells, tissues, and cellular and
tissue-based products (HCT)
 Medical devices (including in vitro diagnostic products)
 Combination products
 Special nutritional products
(infant formulas, and medical foods)
 Cosmetics
 Foods/beverages (including reports of serious allergic
reactions)
What Not to Report to FDA MedWatch
 Tobacco: Tobacco product problems should be reported to
the Safety Reporting Portal.
 Vaccines: Report vaccine events to the Vaccine Adverse
Event Reporting System (VAERS) online
at https://vaers.hhs.gov/esub/index
 Investigational (study) drugs: Report investigational
(study) drug adverse events as required in the study
protocol and send to the address and contact person listed
in the study protocol.
 Mandatory reporting by regulated industry:
 Drugs and Biologics
 Applicable Regulations
 Devices
 Reporting on Dietary Supplements
 Reporting on Veterinary Medicine Products
 Reports FDA Does Not Handle (e.g. CPSC, FTC, State Health
Departments) and Where to Send Them
What Happens to Your Report
 When you report a serious adverse event
 Report captured in a database
 Database monitored by an FDA professional
 Review of a case series
 Consultation with medical review division and manufacturer
 Further studies as needed are conducted
What Happens to Your Report
 When you provide information on a serious ADE
 Labeling or Educational Options
 Boxed Warning
• Drug-drug, drug-food interaction warnings
• Monitoring recommendations
• Dosage adjustments for sub-populations
 Contraindications, Warnings, Precautions or Adverse Reactions
 Medication Guide
What happens when you report a serious ADE
 Special programs
• Prescribing or dispensing limitations
• Laboratory testing documentation
• Registries for a particular product
 Product withdrawal or product recall
 This depends upon the Adverse event occurred
When you report a product quality problem
 For problems due to:
• Product design
• Manufacturing quality or distribution/storage
• Counterfeit product
 FDA can:
• Work with manufacturer to issue a recall of product
• Request a modification in product design
• Request a modification in manufacturing process
• Improve instructions or warnings for use
FDA MedWatch Summary
 Understand how the FDA monitors medical product safety
 Learn how to voluntarily report adverse events to FDA
 Understand how reports are used by the FDA to improve
product safety
 Know the methods used by FDA to send new safety
information about medical products to providers at the point of
care
Reference
 https://en.wikipedia.org/wiki/MedWatch
 https://www.fda.gov/Safety/MedWatch/SafetyInformation/defa
ult.htm
 https://www.fda.gov/Safety/MedWatch/SafetyInformation/Safe
tyAlertsforHumanMedicalProducts/ucm535957.htm
 https://www.accessdata.fda.gov/scripts/medwatch/index.cfm?a
ction=reporting.home
 https://www.fda.gov/TobaccoProducts/PublicHealthScienceRes
earch/ucm377563.htm
 https://www.safetyreporting.hhs.gov/SRP2/en/Home.aspx?sid=
ee0609ca-f995-4ca3-99db-aa1ce4d564ee
Fda med watch

More Related Content

What's hot

Regulatory requirnment and approval procedure of drugs in japan ppt
Regulatory requirnment and approval procedure of drugs in japan pptRegulatory requirnment and approval procedure of drugs in japan ppt
Regulatory requirnment and approval procedure of drugs in japan pptsandeep bansal
 
Regulatory authority of japan
Regulatory authority of japanRegulatory authority of japan
Regulatory authority of japanAadityaThole
 
Regulatory authorities (US-FDA, WHO and ICH)
Regulatory authorities (US-FDA, WHO and ICH)Regulatory authorities (US-FDA, WHO and ICH)
Regulatory authorities (US-FDA, WHO and ICH)Sagar Savale
 
Usa and canada ppt final ranju hod augst
Usa and canada ppt final ranju hod augstUsa and canada ppt final ranju hod augst
Usa and canada ppt final ranju hod augstRanjiniDM
 
Regulation Governing Clinical Trials In India,USA and Europe.
Regulation Governing Clinical Trials In India,USA and Europe.  Regulation Governing Clinical Trials In India,USA and Europe.
Regulation Governing Clinical Trials In India,USA and Europe. KapilKumar198
 
Regulatory guidelines for the development of biologics in
Regulatory guidelines for the development of biologics inRegulatory guidelines for the development of biologics in
Regulatory guidelines for the development of biologics inJAYA PRAKASH VELUCHURI
 
EUROPEAN MEDICAL AGENCY
EUROPEAN MEDICAL AGENCYEUROPEAN MEDICAL AGENCY
EUROPEAN MEDICAL AGENCYdatchayani
 
GOOD AUTOMATED LABORATORY PRACTICE
GOOD AUTOMATED LABORATORY PRACTICEGOOD AUTOMATED LABORATORY PRACTICE
GOOD AUTOMATED LABORATORY PRACTICEjagrutivasava
 
VOLUME 9A ppt.pptx
VOLUME 9A ppt.pptxVOLUME 9A ppt.pptx
VOLUME 9A ppt.pptxAartiVats5
 
OVERVIEW OF DRUG REGULATORY AGENCIES IN INDIA, USA, EUROPE AND JAPAN
OVERVIEW OF DRUG REGULATORY AGENCIES IN INDIA, USA, EUROPE AND JAPAN OVERVIEW OF DRUG REGULATORY AGENCIES IN INDIA, USA, EUROPE AND JAPAN
OVERVIEW OF DRUG REGULATORY AGENCIES IN INDIA, USA, EUROPE AND JAPAN Arul Packiadhas
 
21CFR 320- BIO AVAILABILITY AND BIO EQUIVALENCE REQUIREMENTS
21CFR 320- BIO AVAILABILITY AND BIO EQUIVALENCE REQUIREMENTS21CFR 320- BIO AVAILABILITY AND BIO EQUIVALENCE REQUIREMENTS
21CFR 320- BIO AVAILABILITY AND BIO EQUIVALENCE REQUIREMENTSPallavi Christeen
 
ANVISA regulatory authority of brazil
ANVISA regulatory authority of brazilANVISA regulatory authority of brazil
ANVISA regulatory authority of brazilGaurav Kr
 
21 cfr part 50
21 cfr part 5021 cfr part 50
21 cfr part 50Rohit K.
 
Regulatory aspects of Biologics in India
Regulatory aspects of Biologics in India Regulatory aspects of Biologics in India
Regulatory aspects of Biologics in India RichaTrivedi16
 
MARKETING AUTHORISATION, LICENSING AND QUALITY ASSESSMENT OF VACCINES IN INDI...
MARKETING AUTHORISATION, LICENSING AND QUALITY ASSESSMENT OF VACCINES IN INDI...MARKETING AUTHORISATION, LICENSING AND QUALITY ASSESSMENT OF VACCINES IN INDI...
MARKETING AUTHORISATION, LICENSING AND QUALITY ASSESSMENT OF VACCINES IN INDI...Swapnil Fernandes
 
Periodic Safety Update Report (PSUR)
Periodic Safety Update Report (PSUR)Periodic Safety Update Report (PSUR)
Periodic Safety Update Report (PSUR)Dr. Rohith K Nair
 
Clinical Research Regulation in European Union
Clinical Research Regulation in European Union Clinical Research Regulation in European Union
Clinical Research Regulation in European Union ShantanuThakre3
 

What's hot (20)

Regulatory requirnment and approval procedure of drugs in japan ppt
Regulatory requirnment and approval procedure of drugs in japan pptRegulatory requirnment and approval procedure of drugs in japan ppt
Regulatory requirnment and approval procedure of drugs in japan ppt
 
An introduction to the EMA
An introduction to the EMAAn introduction to the EMA
An introduction to the EMA
 
Regulatory authority of japan
Regulatory authority of japanRegulatory authority of japan
Regulatory authority of japan
 
Regulatory authorities (US-FDA, WHO and ICH)
Regulatory authorities (US-FDA, WHO and ICH)Regulatory authorities (US-FDA, WHO and ICH)
Regulatory authorities (US-FDA, WHO and ICH)
 
Usa and canada ppt final ranju hod augst
Usa and canada ppt final ranju hod augstUsa and canada ppt final ranju hod augst
Usa and canada ppt final ranju hod augst
 
Regulation Governing Clinical Trials In India,USA and Europe.
Regulation Governing Clinical Trials In India,USA and Europe.  Regulation Governing Clinical Trials In India,USA and Europe.
Regulation Governing Clinical Trials In India,USA and Europe.
 
Regulatory guidelines for the development of biologics in
Regulatory guidelines for the development of biologics inRegulatory guidelines for the development of biologics in
Regulatory guidelines for the development of biologics in
 
EUROPEAN MEDICAL AGENCY
EUROPEAN MEDICAL AGENCYEUROPEAN MEDICAL AGENCY
EUROPEAN MEDICAL AGENCY
 
GOOD AUTOMATED LABORATORY PRACTICE
GOOD AUTOMATED LABORATORY PRACTICEGOOD AUTOMATED LABORATORY PRACTICE
GOOD AUTOMATED LABORATORY PRACTICE
 
VOLUME 9A ppt.pptx
VOLUME 9A ppt.pptxVOLUME 9A ppt.pptx
VOLUME 9A ppt.pptx
 
OVERVIEW OF DRUG REGULATORY AGENCIES IN INDIA, USA, EUROPE AND JAPAN
OVERVIEW OF DRUG REGULATORY AGENCIES IN INDIA, USA, EUROPE AND JAPAN OVERVIEW OF DRUG REGULATORY AGENCIES IN INDIA, USA, EUROPE AND JAPAN
OVERVIEW OF DRUG REGULATORY AGENCIES IN INDIA, USA, EUROPE AND JAPAN
 
21CFR 320- BIO AVAILABILITY AND BIO EQUIVALENCE REQUIREMENTS
21CFR 320- BIO AVAILABILITY AND BIO EQUIVALENCE REQUIREMENTS21CFR 320- BIO AVAILABILITY AND BIO EQUIVALENCE REQUIREMENTS
21CFR 320- BIO AVAILABILITY AND BIO EQUIVALENCE REQUIREMENTS
 
ANVISA regulatory authority of brazil
ANVISA regulatory authority of brazilANVISA regulatory authority of brazil
ANVISA regulatory authority of brazil
 
21 cfr part 50
21 cfr part 5021 cfr part 50
21 cfr part 50
 
Regulatory aspects of Biologics in India
Regulatory aspects of Biologics in India Regulatory aspects of Biologics in India
Regulatory aspects of Biologics in India
 
MARKETING AUTHORISATION, LICENSING AND QUALITY ASSESSMENT OF VACCINES IN INDI...
MARKETING AUTHORISATION, LICENSING AND QUALITY ASSESSMENT OF VACCINES IN INDI...MARKETING AUTHORISATION, LICENSING AND QUALITY ASSESSMENT OF VACCINES IN INDI...
MARKETING AUTHORISATION, LICENSING AND QUALITY ASSESSMENT OF VACCINES IN INDI...
 
EUROPEAN MEDICINE AGENCY.pptx
EUROPEAN MEDICINE AGENCY.pptxEUROPEAN MEDICINE AGENCY.pptx
EUROPEAN MEDICINE AGENCY.pptx
 
Periodic Safety Update Report (PSUR)
Periodic Safety Update Report (PSUR)Periodic Safety Update Report (PSUR)
Periodic Safety Update Report (PSUR)
 
ACTD- ASEAN
ACTD- ASEANACTD- ASEAN
ACTD- ASEAN
 
Clinical Research Regulation in European Union
Clinical Research Regulation in European Union Clinical Research Regulation in European Union
Clinical Research Regulation in European Union
 

Similar to Fda med watch

Pharmacovigilance sytem in United States of America (USA)
Pharmacovigilance sytem in United States of America (USA)Pharmacovigilance sytem in United States of America (USA)
Pharmacovigilance sytem in United States of America (USA)PharmXL International Pvt. Ltd.
 
Fda adverse event reporting requirements for otc drugs
Fda adverse event reporting requirements  for otc drugsFda adverse event reporting requirements  for otc drugs
Fda adverse event reporting requirements for otc drugscomplianceonline123
 
Fda adverse event reporting requirements for otc drugs
Fda adverse event reporting requirements for otc drugsFda adverse event reporting requirements for otc drugs
Fda adverse event reporting requirements for otc drugsComplianceOnline
 
ADR reporting (Clinical Research & Pharmacovigilance).pptx
ADR reporting (Clinical Research & Pharmacovigilance).pptxADR reporting (Clinical Research & Pharmacovigilance).pptx
ADR reporting (Clinical Research & Pharmacovigilance).pptxDureshahwar khan
 
METHODS OF POST MARKETING SURVEILLANCE
METHODS OF POST MARKETING SURVEILLANCEMETHODS OF POST MARKETING SURVEILLANCE
METHODS OF POST MARKETING SURVEILLANCEDr Arathy R Nath
 
Side effects of drugs products, medical devices & drugs healthcare data...
Side effects of drugs products, medical devices & drugs   healthcare data...Side effects of drugs products, medical devices & drugs   healthcare data...
Side effects of drugs products, medical devices & drugs healthcare data...PEPGRA Healthcare
 
Best Practice Document on Handling of Market Complaints.pdf
Best Practice Document on Handling of Market Complaints.pdfBest Practice Document on Handling of Market Complaints.pdf
Best Practice Document on Handling of Market Complaints.pdfTom Aspinall
 
TGA presentation: Postmarket Monitoring
TGA presentation: Postmarket MonitoringTGA presentation: Postmarket Monitoring
TGA presentation: Postmarket MonitoringTGA Australia
 
Reporting adverse events under COVID-19 to FDA
Reporting adverse events under COVID-19 to FDAReporting adverse events under COVID-19 to FDA
Reporting adverse events under COVID-19 to FDAChristine Zomorodian
 
Postmarket monitoring of therapeutic goods in Australia
Postmarket monitoring of therapeutic goods in AustraliaPostmarket monitoring of therapeutic goods in Australia
Postmarket monitoring of therapeutic goods in AustraliaTGA Australia
 
Pharmacovigilance by bishnu koirala
Pharmacovigilance by bishnu koiralaPharmacovigilance by bishnu koirala
Pharmacovigilance by bishnu koiralaBishnu Koirala
 
post marketing surveillance OF DRUG PRODUCTS
post marketing surveillance OF DRUG PRODUCTSpost marketing surveillance OF DRUG PRODUCTS
post marketing surveillance OF DRUG PRODUCTSPrakashGoudanavar
 
Recall of ph product
Recall of ph productRecall of ph product
Recall of ph productAhmed Suhail
 
An overview -Pharmacovigilance by Pougang Golmei,m.pharm,RIPANS,Mizoram
An overview -Pharmacovigilance by Pougang Golmei,m.pharm,RIPANS,MizoramAn overview -Pharmacovigilance by Pougang Golmei,m.pharm,RIPANS,Mizoram
An overview -Pharmacovigilance by Pougang Golmei,m.pharm,RIPANS,Mizorampougang golmei
 
W hite Paper On Medical Devices
W hite Paper On Medical DevicesW hite Paper On Medical Devices
W hite Paper On Medical DevicesAllisonBooth
 

Similar to Fda med watch (20)

Medwatch and FAERS database
Medwatch and FAERS databaseMedwatch and FAERS database
Medwatch and FAERS database
 
Health Canada Progressive Licensing - Professor Peivand Pirouzi
Health Canada Progressive Licensing - Professor Peivand PirouziHealth Canada Progressive Licensing - Professor Peivand Pirouzi
Health Canada Progressive Licensing - Professor Peivand Pirouzi
 
Pharmacovigilance sytem in United States of America (USA)
Pharmacovigilance sytem in United States of America (USA)Pharmacovigilance sytem in United States of America (USA)
Pharmacovigilance sytem in United States of America (USA)
 
Fda adverse event reporting requirements for otc drugs
Fda adverse event reporting requirements  for otc drugsFda adverse event reporting requirements  for otc drugs
Fda adverse event reporting requirements for otc drugs
 
Fda adverse event reporting requirements for otc drugs
Fda adverse event reporting requirements for otc drugsFda adverse event reporting requirements for otc drugs
Fda adverse event reporting requirements for otc drugs
 
ADR reporting (Clinical Research & Pharmacovigilance).pptx
ADR reporting (Clinical Research & Pharmacovigilance).pptxADR reporting (Clinical Research & Pharmacovigilance).pptx
ADR reporting (Clinical Research & Pharmacovigilance).pptx
 
METHODS OF POST MARKETING SURVEILLANCE
METHODS OF POST MARKETING SURVEILLANCEMETHODS OF POST MARKETING SURVEILLANCE
METHODS OF POST MARKETING SURVEILLANCE
 
Pharmacovigilance
PharmacovigilancePharmacovigilance
Pharmacovigilance
 
Side effects of drugs products, medical devices & drugs healthcare data...
Side effects of drugs products, medical devices & drugs   healthcare data...Side effects of drugs products, medical devices & drugs   healthcare data...
Side effects of drugs products, medical devices & drugs healthcare data...
 
Best Practice Document on Handling of Market Complaints.pdf
Best Practice Document on Handling of Market Complaints.pdfBest Practice Document on Handling of Market Complaints.pdf
Best Practice Document on Handling of Market Complaints.pdf
 
TGA presentation: Postmarket Monitoring
TGA presentation: Postmarket MonitoringTGA presentation: Postmarket Monitoring
TGA presentation: Postmarket Monitoring
 
Reporting adverse events under COVID-19 to FDA
Reporting adverse events under COVID-19 to FDAReporting adverse events under COVID-19 to FDA
Reporting adverse events under COVID-19 to FDA
 
Postmarket monitoring of therapeutic goods in Australia
Postmarket monitoring of therapeutic goods in AustraliaPostmarket monitoring of therapeutic goods in Australia
Postmarket monitoring of therapeutic goods in Australia
 
Pharmacovigilance by bishnu koirala
Pharmacovigilance by bishnu koiralaPharmacovigilance by bishnu koirala
Pharmacovigilance by bishnu koirala
 
clinical Research and pharmacovigilance.pptx
clinical Research and pharmacovigilance.pptxclinical Research and pharmacovigilance.pptx
clinical Research and pharmacovigilance.pptx
 
Spontaneous Reporting System
Spontaneous Reporting SystemSpontaneous Reporting System
Spontaneous Reporting System
 
post marketing surveillance OF DRUG PRODUCTS
post marketing surveillance OF DRUG PRODUCTSpost marketing surveillance OF DRUG PRODUCTS
post marketing surveillance OF DRUG PRODUCTS
 
Recall of ph product
Recall of ph productRecall of ph product
Recall of ph product
 
An overview -Pharmacovigilance by Pougang Golmei,m.pharm,RIPANS,Mizoram
An overview -Pharmacovigilance by Pougang Golmei,m.pharm,RIPANS,MizoramAn overview -Pharmacovigilance by Pougang Golmei,m.pharm,RIPANS,Mizoram
An overview -Pharmacovigilance by Pougang Golmei,m.pharm,RIPANS,Mizoram
 
W hite Paper On Medical Devices
W hite Paper On Medical DevicesW hite Paper On Medical Devices
W hite Paper On Medical Devices
 

More from Sridhar S

TSE/BSE Evaluation
TSE/BSE EvaluationTSE/BSE Evaluation
TSE/BSE EvaluationSridhar S
 
Regulatory requirements for drug approval in Saudi Arabia
Regulatory requirements for drug approval in Saudi ArabiaRegulatory requirements for drug approval in Saudi Arabia
Regulatory requirements for drug approval in Saudi ArabiaSridhar S
 
Plasma master file
Plasma master filePlasma master file
Plasma master fileSridhar S
 
Bis standards
Bis standardsBis standards
Bis standardsSridhar S
 
FDA Warning letter
FDA Warning letterFDA Warning letter
FDA Warning letterSridhar S
 
Site master file
Site master fileSite master file
Site master fileSridhar S
 

More from Sridhar S (6)

TSE/BSE Evaluation
TSE/BSE EvaluationTSE/BSE Evaluation
TSE/BSE Evaluation
 
Regulatory requirements for drug approval in Saudi Arabia
Regulatory requirements for drug approval in Saudi ArabiaRegulatory requirements for drug approval in Saudi Arabia
Regulatory requirements for drug approval in Saudi Arabia
 
Plasma master file
Plasma master filePlasma master file
Plasma master file
 
Bis standards
Bis standardsBis standards
Bis standards
 
FDA Warning letter
FDA Warning letterFDA Warning letter
FDA Warning letter
 
Site master file
Site master fileSite master file
Site master file
 

Recently uploaded

VIP Russian Call Girls in Cuttack Deepika 8250192130 Independent Escort Servi...
VIP Russian Call Girls in Cuttack Deepika 8250192130 Independent Escort Servi...VIP Russian Call Girls in Cuttack Deepika 8250192130 Independent Escort Servi...
VIP Russian Call Girls in Cuttack Deepika 8250192130 Independent Escort Servi...Suhani Kapoor
 
ΦΑΓΗΤΟ ΤΕΛΕΙΟ ΞΞΞΞΞΞΞ ΞΞΞΞΞΞ ΞΞΞΞ ΞΞΞΞ Ξ
ΦΑΓΗΤΟ ΤΕΛΕΙΟ ΞΞΞΞΞΞΞ ΞΞΞΞΞΞ ΞΞΞΞ ΞΞΞΞ ΞΦΑΓΗΤΟ ΤΕΛΕΙΟ ΞΞΞΞΞΞΞ ΞΞΞΞΞΞ ΞΞΞΞ ΞΞΞΞ Ξ
ΦΑΓΗΤΟ ΤΕΛΕΙΟ ΞΞΞΞΞΞΞ ΞΞΞΞΞΞ ΞΞΞΞ ΞΞΞΞ Ξlialiaskou00
 
The Billo Photo Gallery - Cultivated Cuisine T1
The Billo Photo Gallery - Cultivated Cuisine T1The Billo Photo Gallery - Cultivated Cuisine T1
The Billo Photo Gallery - Cultivated Cuisine T1davew9
 
(ISHITA) Call Girls Manchar ( 7001035870 ) HI-Fi Pune Escorts Service
(ISHITA) Call Girls Manchar ( 7001035870 ) HI-Fi Pune Escorts Service(ISHITA) Call Girls Manchar ( 7001035870 ) HI-Fi Pune Escorts Service
(ISHITA) Call Girls Manchar ( 7001035870 ) HI-Fi Pune Escorts Serviceranjana rawat
 
Let Me Relax Dubai Russian Call girls O56338O268 Dubai Call girls AgenCy
Let Me Relax Dubai Russian Call girls O56338O268 Dubai Call girls AgenCyLet Me Relax Dubai Russian Call girls O56338O268 Dubai Call girls AgenCy
Let Me Relax Dubai Russian Call girls O56338O268 Dubai Call girls AgenCystephieert
 
Week 5 Dessert Accompaniments (Cookery 9)
Week 5 Dessert Accompaniments (Cookery 9)Week 5 Dessert Accompaniments (Cookery 9)
Week 5 Dessert Accompaniments (Cookery 9)MAARLENEVIDENA
 
Jp Nagar Call Girls Bangalore WhatsApp 8250192130 High Profile Service
Jp Nagar Call Girls Bangalore WhatsApp 8250192130 High Profile ServiceJp Nagar Call Girls Bangalore WhatsApp 8250192130 High Profile Service
Jp Nagar Call Girls Bangalore WhatsApp 8250192130 High Profile ServiceHigh Profile Call Girls
 
High Class Call Girls Nashik Priya 7001305949 Independent Escort Service Nashik
High Class Call Girls Nashik Priya 7001305949 Independent Escort Service NashikHigh Class Call Girls Nashik Priya 7001305949 Independent Escort Service Nashik
High Class Call Girls Nashik Priya 7001305949 Independent Escort Service Nashikranjana rawat
 
Grade Eight Quarter 4_Week 6_Cookery.pptx
Grade Eight Quarter 4_Week 6_Cookery.pptxGrade Eight Quarter 4_Week 6_Cookery.pptx
Grade Eight Quarter 4_Week 6_Cookery.pptxKurtGardy
 
Call Girls in Nashik Ila 7001305949 Independent Escort Service Nashik
Call Girls in Nashik Ila 7001305949 Independent Escort Service NashikCall Girls in Nashik Ila 7001305949 Independent Escort Service Nashik
Call Girls in Nashik Ila 7001305949 Independent Escort Service NashikCall Girls in Nagpur High Profile
 
VIP Call Girl Bikaner Aashi 8250192130 Independent Escort Service Bikaner
VIP Call Girl Bikaner Aashi 8250192130 Independent Escort Service BikanerVIP Call Girl Bikaner Aashi 8250192130 Independent Escort Service Bikaner
VIP Call Girl Bikaner Aashi 8250192130 Independent Escort Service BikanerSuhani Kapoor
 
Low Rate Call Girls Nagpur Esha Call 7001035870 Meet With Nagpur Escorts
Low Rate Call Girls Nagpur Esha Call 7001035870 Meet With Nagpur EscortsLow Rate Call Girls Nagpur Esha Call 7001035870 Meet With Nagpur Escorts
Low Rate Call Girls Nagpur Esha Call 7001035870 Meet With Nagpur Escortsranjana rawat
 
BPP NC II Lesson 3 - Pastry Products.pptx
BPP NC II Lesson 3 - Pastry Products.pptxBPP NC II Lesson 3 - Pastry Products.pptx
BPP NC II Lesson 3 - Pastry Products.pptxmaricel769799
 
4th QT WEEK 2 Cook Meat Cuts part 2.pptx
4th QT WEEK 2 Cook Meat Cuts part 2.pptx4th QT WEEK 2 Cook Meat Cuts part 2.pptx
4th QT WEEK 2 Cook Meat Cuts part 2.pptxKattieAlisonMacatugg1
 
College Call Girls Nashik Ria 7001305949 Independent Escort Service Nashik
College Call Girls Nashik Ria 7001305949 Independent Escort Service NashikCollege Call Girls Nashik Ria 7001305949 Independent Escort Service Nashik
College Call Girls Nashik Ria 7001305949 Independent Escort Service Nashikranjana rawat
 
THE ARTISANAL SALT OF SAN VICENTE, ILOCOS SUR: A CASE STUDY
THE ARTISANAL SALT OF SAN VICENTE, ILOCOS SUR: A CASE STUDYTHE ARTISANAL SALT OF SAN VICENTE, ILOCOS SUR: A CASE STUDY
THE ARTISANAL SALT OF SAN VICENTE, ILOCOS SUR: A CASE STUDYHumphrey A Beña
 
Russian Call Girls in Nagpur Devyani Call 7001035870 Meet With Nagpur Escorts
Russian Call Girls in Nagpur Devyani Call 7001035870 Meet With Nagpur EscortsRussian Call Girls in Nagpur Devyani Call 7001035870 Meet With Nagpur Escorts
Russian Call Girls in Nagpur Devyani Call 7001035870 Meet With Nagpur EscortsCall Girls in Nagpur High Profile
 
(PRIYANKA) Katraj Call Girls Just Call 7001035870 [ Cash on Delivery ] Pune E...
(PRIYANKA) Katraj Call Girls Just Call 7001035870 [ Cash on Delivery ] Pune E...(PRIYANKA) Katraj Call Girls Just Call 7001035870 [ Cash on Delivery ] Pune E...
(PRIYANKA) Katraj Call Girls Just Call 7001035870 [ Cash on Delivery ] Pune E...ranjana rawat
 

Recently uploaded (20)

VIP Russian Call Girls in Cuttack Deepika 8250192130 Independent Escort Servi...
VIP Russian Call Girls in Cuttack Deepika 8250192130 Independent Escort Servi...VIP Russian Call Girls in Cuttack Deepika 8250192130 Independent Escort Servi...
VIP Russian Call Girls in Cuttack Deepika 8250192130 Independent Escort Servi...
 
ΦΑΓΗΤΟ ΤΕΛΕΙΟ ΞΞΞΞΞΞΞ ΞΞΞΞΞΞ ΞΞΞΞ ΞΞΞΞ Ξ
ΦΑΓΗΤΟ ΤΕΛΕΙΟ ΞΞΞΞΞΞΞ ΞΞΞΞΞΞ ΞΞΞΞ ΞΞΞΞ ΞΦΑΓΗΤΟ ΤΕΛΕΙΟ ΞΞΞΞΞΞΞ ΞΞΞΞΞΞ ΞΞΞΞ ΞΞΞΞ Ξ
ΦΑΓΗΤΟ ΤΕΛΕΙΟ ΞΞΞΞΞΞΞ ΞΞΞΞΞΞ ΞΞΞΞ ΞΞΞΞ Ξ
 
Dwarka Sector 14 Call Girls Delhi 9999965857 @Sabina Saikh No Advance
Dwarka Sector 14 Call Girls Delhi 9999965857 @Sabina Saikh No AdvanceDwarka Sector 14 Call Girls Delhi 9999965857 @Sabina Saikh No Advance
Dwarka Sector 14 Call Girls Delhi 9999965857 @Sabina Saikh No Advance
 
The Billo Photo Gallery - Cultivated Cuisine T1
The Billo Photo Gallery - Cultivated Cuisine T1The Billo Photo Gallery - Cultivated Cuisine T1
The Billo Photo Gallery - Cultivated Cuisine T1
 
(ISHITA) Call Girls Manchar ( 7001035870 ) HI-Fi Pune Escorts Service
(ISHITA) Call Girls Manchar ( 7001035870 ) HI-Fi Pune Escorts Service(ISHITA) Call Girls Manchar ( 7001035870 ) HI-Fi Pune Escorts Service
(ISHITA) Call Girls Manchar ( 7001035870 ) HI-Fi Pune Escorts Service
 
Let Me Relax Dubai Russian Call girls O56338O268 Dubai Call girls AgenCy
Let Me Relax Dubai Russian Call girls O56338O268 Dubai Call girls AgenCyLet Me Relax Dubai Russian Call girls O56338O268 Dubai Call girls AgenCy
Let Me Relax Dubai Russian Call girls O56338O268 Dubai Call girls AgenCy
 
Week 5 Dessert Accompaniments (Cookery 9)
Week 5 Dessert Accompaniments (Cookery 9)Week 5 Dessert Accompaniments (Cookery 9)
Week 5 Dessert Accompaniments (Cookery 9)
 
Jp Nagar Call Girls Bangalore WhatsApp 8250192130 High Profile Service
Jp Nagar Call Girls Bangalore WhatsApp 8250192130 High Profile ServiceJp Nagar Call Girls Bangalore WhatsApp 8250192130 High Profile Service
Jp Nagar Call Girls Bangalore WhatsApp 8250192130 High Profile Service
 
High Class Call Girls Nashik Priya 7001305949 Independent Escort Service Nashik
High Class Call Girls Nashik Priya 7001305949 Independent Escort Service NashikHigh Class Call Girls Nashik Priya 7001305949 Independent Escort Service Nashik
High Class Call Girls Nashik Priya 7001305949 Independent Escort Service Nashik
 
Grade Eight Quarter 4_Week 6_Cookery.pptx
Grade Eight Quarter 4_Week 6_Cookery.pptxGrade Eight Quarter 4_Week 6_Cookery.pptx
Grade Eight Quarter 4_Week 6_Cookery.pptx
 
Call Girls in Nashik Ila 7001305949 Independent Escort Service Nashik
Call Girls in Nashik Ila 7001305949 Independent Escort Service NashikCall Girls in Nashik Ila 7001305949 Independent Escort Service Nashik
Call Girls in Nashik Ila 7001305949 Independent Escort Service Nashik
 
VIP Call Girl Bikaner Aashi 8250192130 Independent Escort Service Bikaner
VIP Call Girl Bikaner Aashi 8250192130 Independent Escort Service BikanerVIP Call Girl Bikaner Aashi 8250192130 Independent Escort Service Bikaner
VIP Call Girl Bikaner Aashi 8250192130 Independent Escort Service Bikaner
 
Low Rate Call Girls Nagpur Esha Call 7001035870 Meet With Nagpur Escorts
Low Rate Call Girls Nagpur Esha Call 7001035870 Meet With Nagpur EscortsLow Rate Call Girls Nagpur Esha Call 7001035870 Meet With Nagpur Escorts
Low Rate Call Girls Nagpur Esha Call 7001035870 Meet With Nagpur Escorts
 
BPP NC II Lesson 3 - Pastry Products.pptx
BPP NC II Lesson 3 - Pastry Products.pptxBPP NC II Lesson 3 - Pastry Products.pptx
BPP NC II Lesson 3 - Pastry Products.pptx
 
4th QT WEEK 2 Cook Meat Cuts part 2.pptx
4th QT WEEK 2 Cook Meat Cuts part 2.pptx4th QT WEEK 2 Cook Meat Cuts part 2.pptx
4th QT WEEK 2 Cook Meat Cuts part 2.pptx
 
5th Annual International OMGD Grand Chapitre: A Spanish Wine Journey
5th Annual International OMGD Grand Chapitre: A Spanish Wine Journey5th Annual International OMGD Grand Chapitre: A Spanish Wine Journey
5th Annual International OMGD Grand Chapitre: A Spanish Wine Journey
 
College Call Girls Nashik Ria 7001305949 Independent Escort Service Nashik
College Call Girls Nashik Ria 7001305949 Independent Escort Service NashikCollege Call Girls Nashik Ria 7001305949 Independent Escort Service Nashik
College Call Girls Nashik Ria 7001305949 Independent Escort Service Nashik
 
THE ARTISANAL SALT OF SAN VICENTE, ILOCOS SUR: A CASE STUDY
THE ARTISANAL SALT OF SAN VICENTE, ILOCOS SUR: A CASE STUDYTHE ARTISANAL SALT OF SAN VICENTE, ILOCOS SUR: A CASE STUDY
THE ARTISANAL SALT OF SAN VICENTE, ILOCOS SUR: A CASE STUDY
 
Russian Call Girls in Nagpur Devyani Call 7001035870 Meet With Nagpur Escorts
Russian Call Girls in Nagpur Devyani Call 7001035870 Meet With Nagpur EscortsRussian Call Girls in Nagpur Devyani Call 7001035870 Meet With Nagpur Escorts
Russian Call Girls in Nagpur Devyani Call 7001035870 Meet With Nagpur Escorts
 
(PRIYANKA) Katraj Call Girls Just Call 7001035870 [ Cash on Delivery ] Pune E...
(PRIYANKA) Katraj Call Girls Just Call 7001035870 [ Cash on Delivery ] Pune E...(PRIYANKA) Katraj Call Girls Just Call 7001035870 [ Cash on Delivery ] Pune E...
(PRIYANKA) Katraj Call Girls Just Call 7001035870 [ Cash on Delivery ] Pune E...
 

Fda med watch

  • 1. Presented By:- Sridhar S 1st M.Pharmacy Pharmaceutical Regulatory Affairs JSS College of Pharmacy Mysuru-15
  • 2. Definition  MedWatch is the Food and Drug Administration’s Safety Information and Adverse Event Reporting Program. MedWatch is used for reporting an adverse event, founded in 1993  this system of voluntary reporting allows such information to be shared with the medical community or the general public. The system includes publicly available databases and online analysis tools for professionals.  MedWatch also disseminates medical product safety alerts such as recalls and other clinical safety communications via its website, email list
  • 3. Reporting Adverse Events to FDA  Industry  ICH E2B electronic standard (clinical safety data management)  MedWatch form 3500A  Public  MedWatch 3500  MedWatch 3500B
  • 4. Med Watch program goals  Reporting IN  Educate about importance of reporting  Facilitate the reporting  Improve the quality of the reports  Safety Information OUT  Disseminate clinically useful, new safety information to providers and patients
  • 5. Mission and History  “Protecting the public health by assuring the safety, efficacy, and security of human ... drugs, biological products, medical devices, cosmetics, and products that emit radiation.”( from FDA Mission Statement)  Helping the public get the accurate, science-based information they need to use medicines and foods to improve their health
  • 6. How FDA Evaluates Medical Product Safety  Pre-Market Review and Approval • FDA does not develop or routinely test products itself • FDA reviews the results of laboratory, animal, and human clinical testing done by companies  Post-Market Monitoring for Safety • Careful review of adverse experiences with products once they are marketed
  • 7. Reporting In to MedWatch  What, when, how and why to report  What  All clinical medical products  When  If serious and any adverse reaction  How  Online, or mail/fax/phone  Why  Every report can make a difference
  • 8. What is a serious adverse event  1) Death  2) Life-threatening adverse drug experience  3) Inpatient hospitalization or prolongation of existing hospitalization (for > 24 hours)  4) Persistent or significant incapacity or substantial disruption of the ability to conduct normal life functions
  • 9.  5) Congenital anomaly/birth defect  6) Important Medical Event (IME) that may not result in death, be life threatening, or require hospitalization may be considered a serious adverse drug experience
  • 10. Forms to reporting to FDA  FORM FDA 3500-Voluentary reporting  For use by healthcare professionals, consumers, and patients. Submit the completed form using built-in postage-paid mailer, or fax.  FORM FDA 3500B-Voluentary reporting for consumers  A consumer-friendly version of the 3500 reporting form. Submit the completed form using address on page 3 of the form, or fax.
  • 11.  FORM FDA 3500A-Mandatory reporting  For use by IND reporters, manufacturers, distributors, importers, user facilities personnel  Online Reporting Form (Voluntary Reporting)  Report serious adverse events online for human medical products, including potential and actual product use errors, product quality problems, and therapeutic inequivalence/failure. The introductory page features additional information and instructions.
  • 14.
  • 15. Safety reporting portal  To report adverse events with tobacco products or dietary supplements online, use the Safety Reporting Portal  Tobacco  If you experience a problem with a tobacco product, such as an unexpected health or safety issue, report it online using the Safety Reporting Portal.  Dietary Supplements  Dietary supplements include vitamins, minerals, herbs, amino acids, whey protein, creatine, and weight loss pills
  • 16.  Radiation-emitting Products  The radiation emitting products like medical devices and radio isotopes are reported to the FDA by safety reporting portal  Any accidental radiation occurrences arising from the manufacturing, testing, or use of any product introduced or intended to be introduced into commerce
  • 17.
  • 18. MedWatch Website Safety Reporting Information Monthly Safety Summaries Individual Safety Alerts
  • 19. Who Should Submit a Safety Report?  Organizations and people in certain professional roles, such as the following:-  Food Manufacturers, Processors, Packers, and Holders  Researchers  An applicant of an approved drug product or a manufacturer, distributor or packer listed on the label of any drug product  Drug Manufacturers  Dietary supplement manufacturers, packers, and distributors
  • 20.  Others, including healthcare providers, public health officials, and other professionals, as well as consumers and concerned citizens, may voluntarily submit reports if they encounter safety issues with a product and/or unanticipated harmful effects that they believe are related to a product.
  • 21. What to Report to FDA MedWatch  Use the MedWatch form to report adverse events that you observe or suspect for human medical products, including serious drug side effects, medication errors/product use errors, product quality problems, and therapeutic failures for:-  Prescription or over-the-counter medicines, as well as medicines administered to hospital patients or at outpatient infusion centers  Biologics (including blood components, blood and plasma derivatives, allergenic, human cells, tissues, and cellular and tissue-based products (HCT)
  • 22.  Medical devices (including in vitro diagnostic products)  Combination products  Special nutritional products (infant formulas, and medical foods)  Cosmetics  Foods/beverages (including reports of serious allergic reactions)
  • 23. What Not to Report to FDA MedWatch  Tobacco: Tobacco product problems should be reported to the Safety Reporting Portal.  Vaccines: Report vaccine events to the Vaccine Adverse Event Reporting System (VAERS) online at https://vaers.hhs.gov/esub/index  Investigational (study) drugs: Report investigational (study) drug adverse events as required in the study protocol and send to the address and contact person listed in the study protocol.
  • 24.  Mandatory reporting by regulated industry:  Drugs and Biologics  Applicable Regulations  Devices  Reporting on Dietary Supplements  Reporting on Veterinary Medicine Products  Reports FDA Does Not Handle (e.g. CPSC, FTC, State Health Departments) and Where to Send Them
  • 25. What Happens to Your Report  When you report a serious adverse event  Report captured in a database  Database monitored by an FDA professional  Review of a case series  Consultation with medical review division and manufacturer  Further studies as needed are conducted
  • 26. What Happens to Your Report  When you provide information on a serious ADE  Labeling or Educational Options  Boxed Warning • Drug-drug, drug-food interaction warnings • Monitoring recommendations • Dosage adjustments for sub-populations  Contraindications, Warnings, Precautions or Adverse Reactions  Medication Guide
  • 27. What happens when you report a serious ADE  Special programs • Prescribing or dispensing limitations • Laboratory testing documentation • Registries for a particular product  Product withdrawal or product recall  This depends upon the Adverse event occurred
  • 28. When you report a product quality problem  For problems due to: • Product design • Manufacturing quality or distribution/storage • Counterfeit product  FDA can: • Work with manufacturer to issue a recall of product • Request a modification in product design • Request a modification in manufacturing process • Improve instructions or warnings for use
  • 29. FDA MedWatch Summary  Understand how the FDA monitors medical product safety  Learn how to voluntarily report adverse events to FDA  Understand how reports are used by the FDA to improve product safety  Know the methods used by FDA to send new safety information about medical products to providers at the point of care
  • 30. Reference  https://en.wikipedia.org/wiki/MedWatch  https://www.fda.gov/Safety/MedWatch/SafetyInformation/defa ult.htm  https://www.fda.gov/Safety/MedWatch/SafetyInformation/Safe tyAlertsforHumanMedicalProducts/ucm535957.htm  https://www.accessdata.fda.gov/scripts/medwatch/index.cfm?a ction=reporting.home  https://www.fda.gov/TobaccoProducts/PublicHealthScienceRes earch/ucm377563.htm  https://www.safetyreporting.hhs.gov/SRP2/en/Home.aspx?sid= ee0609ca-f995-4ca3-99db-aa1ce4d564ee